Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Amandeep Salhotra, Karamjeet Sandhu, James O’Hearn, Haris Ali, Ryotaro Nakamura & Badri G Modi. (2023) A critical review of belumosudil in adult and pediatric patients with chronic graft-versus-host disease. Expert Review of Clinical Immunology 19:3, pages 241-251.
Read now
Read now
Marcell Csanadi, Tamas Agh, Attila Tordai, Thomas Webb, Dusha Jeyakumaran, Nishan Sengupta, Frida Schain & Jonas Mattsson. (2019) A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease. Expert Review of Hematology 12:5, pages 311-323.
Read now
Read now
Tamas Agh, Marcell Csanadi, Zoltan Voko, Thomas Webb, Dusha Jeyakumaran, Jeremiah Trudeau, Nishan Sengupta, Frida Schain & Jonas Mattsson. (2019) Humanistic burden of patients with chronic graft-versus-host disease - systematic literature review of health-related quality of life and functional status. Expert Review of Hematology 12:5, pages 295-309.
Read now
Read now
Anne Wanquet, Roberto Crocchiolo, Sabine Furst, Angela Granata, Catherine Faucher, Raynier Devillier, Samia Harbi, Claude Lemarie, Boris Calmels, Norbert Vey, Pierre Jean Weiller, Christian Chabannon, Luca Castagna, Didier Blaise & Jean El-Cheikh. (2016) The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m2 intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia. Leukemia & Lymphoma 57:10, pages 2315-2320.
Read now
Read now
Articles from other publishers (20)
Igor Novitzky-Basso, Christopher Patriquin, Swe Mar Linn, Caden Chiarello, Ivan Pasic, Wilson Lam, Arjun Law, Fotios V. Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey Lipton, Rajat Kumar, Jonas Mattsson, David Barth & Dennis Dong Hwan Kim. (2023) Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHD. Transplantation and Cellular Therapy 29:12, pages 773.e1-773.e10.
Crossref
Crossref
Igor Novitzky-Basso, Swe Mar Linn, Jennifer White, Mohamed Elemary, Anargyros Xenocostas, Uday Deotare, Kate Kelly, Nada Hamad, Sui Tan, Samantha Culos, Arjun Law, Rajat Kumar, Jonas Mattsson & Dennis Dong Hwan Kim. (2023) Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure. Bone Marrow Transplantation.
Crossref
Crossref
Igor Novitzky-Basso, Frida Schain, Nurgul Batyrbekova, Thomas Webb, Mats Remberger, Armand Keating & Jonas Mattsson. (2023) Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease. PLOS ONE 18:3, pages e0282753.
Crossref
Crossref
Shuang Fan, Tian-Zhong Pan, Li-Ping Dou, Yan-Min Zhao, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Xiao-Jun Huang & Xiao-Dong Mo. (2023) Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis. Frontiers in Immunology 14.
Crossref
Crossref
Corey CutlerStephanie J. Lee, Sally Arai, Marcello RottaBehyar ZoghiAleksandr Lazaryan, Aravind RamakrishnanZachariah DeFilipp, Amandeep SalhotraWanxing Chai-HoRohtesh MehtaTrent WangMukta Arora, Iskra PusicAyman Saad, Nirav N. ShahSunil AbhyankarCarlos BachierJohn Galvin, Annie ImAmelia Langston, Jane LiesveldMark Juckett, Aaron LoganLevanto SchachterAsif AlaviDianna HowardHarlan W. WaksalJohn RyanDavid EiznhamerSanjay K. AggarwalJonathan IeyoubOlivier SchuellerLaurie GreenZhongming YangHeidi KrenzMadan JagasiaBruce R. Blazar & Steven Pavletic. (2021) Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study. Blood 138:22, pages 2278-2289.
Crossref
Crossref
Madan Jagasia, Aleksandr Lazaryan, Carlos R. Bachier, Amandeep Salhotra, Daniel J. Weisdorf, Behyar Zoghi, James Essell, Laurie Green, Olivier Schueller, Jeegar Patel, Alexandra Zanin-Zhorov, Jonathan M. Weiss, Zhongming Yang, David Eiznhamer, Sanjay K. Aggarwal, Bruce R. Blazar & Stephanie J. Lee. (2021) ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease. Journal of Clinical Oncology 39:17, pages 1888-1898.
Crossref
Crossref
Fei-Fei Tang, Yi-Fei Cheng, Lan-Ping Xu, Xiao-Hui Zhang, Chen-Hua Yan, Wei Han, Yu-Hong Chen, Xiao-Jun Huang & Yu Wang. (2020) Incidence, Risk Factors, and Outcomes of Chronic Graft-versus-Host Disease in Pediatric Patients with Hematologic Malignancies after T Cell-Replete Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation with Antithymocyte Globulin/Granulocyte Colony-Stimulating Factor. Biology of Blood and Marrow Transplantation 26:9, pages 1655-1662.
Crossref
Crossref
Meng Lv, Xiaohui Zhang, Lanping Xu, Yu Wang, Chenhua Yan, Huan Chen, Yuhong Chen, Wei Han, Fengrong Wang, Jingzhi Wang, Kaiyan Liu, Xiaojun Huang & Xiaodong Mo. (2019) Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia. Frontiers of Medicine 13:6, pages 667-679.
Crossref
Crossref
Rui Ma, Xiao-Jun Huang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Hui Zhang, Chen-Hua Yan, Wei Han, Feng-Rong Wang, Yu-Hong Chen, Huan Chen, Yao Chen, Jing-Zhi Wang & Yu Wang. (2019) Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies. Biology of Blood and Marrow Transplantation 25:6, pages 1210-1217.
Crossref
Crossref
Wen-Jing Yu, Xiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Kai-Yan Liu & Xiao-Jun Huang. (2019) Occurrence and Severity of Donor Lymphocyte Infusion–Associated Chronic Graft-versus-Host Disease Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 25:5, pages 912-920.
Crossref
Crossref
Zimin Sun, Huilan Liu, Chenhui Luo, Liangquan Geng, Changcheng Zheng, Baolin Tang, Xiaoyu Zhu, Juan Tong, Xingbing Wang, Kaiyang Ding, Xiang Wan, Lei Zhang, Wen Yao, Kaiding Song, Xuhan Zhang, Yue Wu, Huizhi Yang, Yongsheng Han, Xin Liu, Weibo Zhu, Jingsheng Wu & Zuyi Wang. (2018) Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study. International Journal of Cancer 143:3, pages 699-708.
Crossref
Crossref
Gabriel Afram, Jose Antonio Pérez Simón, Mats Remberger, Teresa Caballero-Velázquez, Rodrigo Martino, Jose Luis Piñana, Olle Ringden, Albert Esquirol, Lucia Lopez-Corral, Irene Garcia, Oriana López-Godino, Jordi Sierra, Dolores Caballero, Per Ljungman, Lourdes Vazquez & Hans Hägglund. (2018) Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting. Medical Oncology 35:6.
Crossref
Crossref
Z Al-Kadhimi, Z Gul, M Abidi, L G Lum, A Deol, W Chen, H Jang, C Ozust, A Langston, E Waller & J Uberti. (2017) Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention. Bone Marrow Transplantation 52:9, pages 1304-1310.
Crossref
Crossref
Xiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Kai-Yan Liu & Xiao-Jun Huang. (2016) Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation in First Complete Remission Can Abrogate the Poor Outcomes of Children with Acute Myeloid Leukemia Resistant to the First Course of Induction Chemotherapy. Biology of Blood and Marrow Transplantation 22:12, pages 2235-2242.
Crossref
Crossref
Shernan G. HoltanNandita KheraJohn E. LevineXiaoyu ChaiBarry StorerHien D. LiuYoshihiro InamotoGeorge L. ChenSebastian MayerMukta AroraJeanne PalmerMary E. D. FlowersCorey S. CutlerAlexander LukezSally AraiAleksandr LazaryanLaura F. NewellChrista KrupskiMadan H. JagasiaIskra PusicWilliam WoodAnne S. RenteriaGregory YanikWilliam J. HoganElizabeth HexnerFrancis AyukErnst HollerPhandee WatanaboonyongcharoenYvonne A. Efebera, James L. M. FerraraAngela Panoskaltsis-MortariDaniel WeisdorfStephanie J. LeeJoseph Pidala. (2016) Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors. Blood 128:19, pages 2350-2358.
Crossref
Crossref
Xiao-Dong Mo, Bao-Lin Tang, Xiao-Hui Zhang, Chang-Cheng Zheng, Lan-Ping Xu, Xiao-Yu Zhu, Yu Wang, Hui-Lan Liu, Chen-Hua Yan, Xian-Deng Chu, Huan Chen, Liang-Quan Geng, Kai-Yan Liu, Zi-Min Sun & Xiao-Jun Huang. (2016) Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia. International Journal of Cancer 139:9, pages 2106-2115.
Crossref
Crossref
Xiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Kai-Yan Liu & Xiao-Jun Huang. (2016) Salvage chemotherapy followed by granulocyte colony-stimulating factor-primed donor leukocyte infusion with graft-vs.-host disease control for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell tra. European Journal of Haematology 96:3, pages 297-308.
Crossref
Crossref
X-D Mo, L-P Xu, X-H Zhang, D-H Liu, Y Wang, H Chen, C-H Yan, Y-H Chen, W Han, F-R Wang, J-Z Wang, K-Y Liu & X-J Huang. (2014) Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndrome. Bone Marrow Transplantation 50:1, pages 127-133.
Crossref
Crossref
Jonathan Brammer & Shernan Holtan. 2015. Blood and Marrow Transplant Handbook. Blood and Marrow Transplant Handbook
245
258
.
Nicoletta Cieri, Sara Mastaglio, Giacomo Oliveira, Monica Casucci, Attilio Bondanza & Chiara Bonini. (2014) Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation. Immunological Reviews 257:1, pages 165-180.
Crossref
Crossref